Turning Point Therapeutics Inc (TPTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | TPTX | AMLX | NAMS | ||
| Company | Turning Point Therapeutics Inc | Amylyx Pharmaceuticals Inc | Newamsterdam Pharma Company N.V. | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 75.99 | 37.13 | 27.22 | ||
| High | 76.01 | 37.18 | 27.39 | ||
| Low | 75.98 | 35.79 | 26.71 | ||
| Last | 76.01 | 36.41 | 27.31 | ||
| Change | +0.52 | -1.05 | -0.03 | ||
| Percent Change | +0.69% | -2.80% | -0.11% | ||
| Volume | 2,843,300 | 891,276 | 326,233 | ||
| 20-Day Average Volume | 962,475 | 3,897,358 | 1,106,517 | ||
| Previous | 75.49 | 37.46 | 27.34 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 75.11 | 27.56 | 27.56 | ||
| 20-Day Raw Stochastic | 100.00% | 78.74% | 45.82% | ||
| 20-Day Relative Strength | 74.20 | 73.67 | 42.08 | ||
| Weighted Alpha | -18.70 | +167.83 | -16.59 | ||
| Today's Opinion | 96% Buy | 100% Buy | 100% Sell | ||
| Yesterday's Opinion | 96% Buy | 100% Buy | 100% Sell | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 56% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 08/09/22 | -5.45% since 08/19/26 | -4.59% since 08/19/26 | ||
| Low | 74.86 on 08/10/22 | 35.89 on 08/26/26 | 26.67 on 08/24/26 | ||
| High | 76.01 on 08/16/22 | 41.14 on 08/21/26 | 28.43 on 08/20/26 | ||
| 1-Month | |||||
| %Chg | +1.82% since 07/15/22 | +98.23% since 07/24/26 | -8.16% since 07/24/26 | ||
| Low | 74.57 on 07/21/22 | 18.08 on 07/27/26 | 25.74 on 08/05/26 | ||
| High | 76.01 on 08/16/22 | 41.14 on 08/21/26 | 31.29 on 07/27/26 | ||
| 3-Month | |||||
| %Chg | +134.02% since 05/16/22 | +166.78% since 05/26/26 | -24.62% since 05/26/26 | ||
| Low | 30.85 on 05/25/22 | 12.62 on 06/08/26 | 25.74 on 08/05/26 | ||
| High | 76.01 on 08/16/22 | 41.14 on 08/21/26 | 37.37 on 07/07/26 | ||
| 6-Month | |||||
| %Chg | +124.48% since 02/16/22 | +139.15% since 02/26/26 | -20.60% since 02/26/26 | ||
| Low | 23.77 on 03/15/22 | 12.44 on 05/19/26 | 25.74 on 08/05/26 | ||
| High | 76.01 on 08/16/22 | 41.14 on 08/21/26 | 42.21 on 05/11/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,806,125 | 4,173,905 | 3,268,142 | ||
| Shares Outstanding, K | 50,074 | 111,423 | 119,537 | ||
| Annual Sales, $M | 30,830,000 | 0 | 22,500,000 | ||
| Annual Net Income, $M | -236,550,000 | -144,740,000 | -203,820,000 | ||
| Last Qtr Sales, $M | 120,000 | 0 | 3,700,000 | ||
| Last Qtr Income, $M | -123,090,000 | -43,420,000 | -64,140,000 | ||
| 60-Month Beta | -0.18 | -0.21 | 0.10 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.48 on 08/08/22 | -0.39 on 08/06/26 | -0.52 on 08/05/26 | ||
| Latest Earnings Date | 11/08/22 | 11/05/26 | 11/04/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | 03/28/18 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||